IFLR1000

Lupin $880 million acquisition of GAVIS Pharmaceuticals

9/3/2016
Private acquisition
Select tab

$ 880 million

Completed

9/3/2016

Overview:

  • Lupin has acquired two pharmaceutical companies - GAVIS Pharmaceuticals and Novel Laboratories, for $880 million.
  • GAVIS  is a New Jersey based pharmaceutical firm.
  • Lupin is a Mumbai based pharmaceutical and the sixth largest generics producers in the US.
  • The combined entities will have 120 products.

Katrin Kostadinova - Data analyst

Jurisdictions:

United States
India

Deal type:

Private acquisition

Practice area:

M&A

Governing law:

India

Industry sector:

Pharmaceuticals and life sciences

Firms:
Brown Rudnick

Party: Lupin (Acquirer)

Latham & Watkins

Party: Gavis Pharmaceuticals (Target)

Related deals